Exelixis Stock Price (NASDAQ:EXEL)

Add to My Stocks
$16.67 $0.8 (5.04%) EXEL stock closing price Sep 18, 2018 (Closing)
Prev Close* : $15.87
Market Cap:
Day Low: $16.04
52 Week Low: $15.81
Open: $16.13
Volume: -
Day High: $16.89
52 Week High: $32.50

Latest Stock Market News

Latest Articles

Exelixis News - From Partners

EXEL Stockcharts

View EXEL PE ratio, PS ratio stocks charts and compare with peers.
EXEL Chart
Note: Compare Exelixis stock price history with the index and industry peers.

Exelixis Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Exelixis Returns

(return on equity)

Exelixis Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

EXEL Industry Peers

Company Price Change (%)
Dyax (DYAX)38.410 (0%)
Ligand Pharma (LGND)265.7212.05 (4.75%)
Sanofi (SNY)43.960.21 (0.48%)
Swedish Orphan (SWTUY)29.380 (0%)
Amgen (AMGN)202.341.53 (0.76%)
Pfizer (PFE)43.510.5 (1.16%)
Swedish Orphan (SWTUY)29.380 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ZIOPHARM Oncology (ZIOP)30.29 (10.7%)
Fate Therapeutics (FATE)12.21.13 (10.21%)
Array BioPharma (ARRY)14.670.94 (6.85%)
Verastem (VSTM)8.760.52 (6.31%)
Puma Biotech (PBYI)46.752.65 (6.01%)
Cara Therapeutics (CARA)22.381.18 (5.57%)
Exelixis (EXEL)16.670.8 (5.04%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 19, 2018
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)2.6250.18 (6.43%)
ELOXX PHARMACT (ELOX)13.350.81 (5.72%)
Alder BioPharma (ALDR)16.350.7 (4.11%)
AMAG Pharma (AMAG)20.950.7 (3.23%)
Enzo Biochem (ENZ)4.540.13 (2.78%)
Amarin (AMRN)2.760.07 (2.47%)
Idera Pharma (IDRA)7.990.2 (2.44%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 19, 2018

Exelixis, Inc. Stock News - Partner Headlines

Exelixis Financial Statements

income statement20172016201520142013
Net Sales or Revenues452.47M191.45M37.17M25.11M31.33M
Net Income154.22M-70.22M-169.73M-268.54M-244.76M
Total Operating Expense271.5M213.01M154.69M247.52M230.94M
View Exelixis income statement
balance sheet20172016201520142013
Total Assets655.29M597.54M332.34M327.96M503.28M
Total Liabilities370.33M508.22M436.64M442.78M437.04M
Shareholders Equity284.96M89.31M-104.3M-114.82M66.23M
View Exelixis balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-6.94M227.26M-25.84M-10.27M-2.26M
Net Cash from (used by) Operating Activities165.61M206.29M-141.58M-235.4M-198.77M
Increase (Decrease) in Prop Plant And Equipment-20.97M-1.6M--0.08M-2.02M
View Exelixis cash flow statement

Exelixis Stock Message Board

Exelixis stock gained 5.04%, and the last close price as of Sep 18, 2018 is $16.67 for EXEL stock. The total market value as denoted by $4.73B for Exelixis, is the market value of the company's outstanding shares. Exelixis valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Exelixis is worth a lot, it will most likely be reflected in an inflated Exelixis stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 5,674,802 on the last trading day, as is evident from Exelixis stock chart, and EXEL stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Exelixis dividend per share was 0.00 during the last quarter. Exelixis stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.